Avricore Health (AVCRF) Long-Term Deferred Tax (2014 - 2021)
Avricore Health (AVCRF) posted quarterly Long-Term Deferred Tax of -$4.7 million for Q4 2021, down 9.97% year-over-year from -$5.3 million in Q4 2020, and down 9.97% quarter-over-quarter from -$4.3 million in Q4 2020.
Avricore Health (AVCRF) Long-Term Deferred Tax (2014 - 2021) Analysis & Trends
Avricore Health (AVCRF) has reported Long-Term Deferred Tax for 4 consecutive years, with -$4.7 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Long-Term Deferred Tax fell 9.97% year-over-year to -$4.7 million; the TTM figure through Dec 2021 stood at -$4.7 million (down 9.97% YoY), while the FY2021 annual figure was -$4.8 million, down 13.66% from the prior year.
- Long-Term Deferred Tax declined to -$4.7 million in Q4 2021 per AVCRF's latest filing, from -$4.3 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at -$4.3 million in Q4 2020 and bottomed at -$4.7 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -4.75 Mn |
| Dec 31, 2020 | -4.32 Mn |
| Jun 30, 2015 | 743,845.15 |
| Jun 30, 2014 | 267,040.39 |